Curis | CRIS - Current Liabilities


Curis reported $14.08M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 813K 108K Dec/2025
Amgen USD 24.96B 534M Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
Bayer EUR 32.58B 3.63B Dec/2025
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Eli Lilly USD 36.63B 1.41B Mar/2026
Exelixis USD 405.64M 31.86M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Incyte USD 1.49B 25.52M Mar/2026
Merck USD 26.94B 1.38B Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Takeda JPY 2.61T 470.53B Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
Verastem USD 72.27M 12.56M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025